Associate Director, Integrated Pharmacovigilance Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kailera Therapeutics · 3 days ago

Associate Director, Integrated Pharmacovigilance Operations

Kailera Therapeutics is committed to developing therapies that empower individuals to transform their lives and enhance their health. The Associate Director, Integrated Pharmacovigilance Operations will oversee pharmacovigilance operational activities, ensuring compliance with global regulatory requirements and contributing to the development of pharmacovigilance strategies and efficiencies.

BiotechnologyPharmaceuticalTherapeutics

Responsibilities

Ensure compliance with global regulatory guidance and requirements (e.g., ICH, FDA, EMA, MHRA, TGA, etc.) and ICH-GCP/ICH-E2E guidelines to meet all applicable safety reporting requirements
Ensure that Individual Case Safety Reports (ICSR) and queries for assigned products are Reviewed for completeness and accuracy and submitted/distributed per global requirements and applicable SOP
Assist with data reconciliation and support safety signal management and aggregate data review activities
Contribute to the preparation and review of Safety Management Plans (SMP) for clinical trials
Support the continuous sponsor oversight of the global safety database and safety vendor activities with appropriate governance implementation
Assist with the development and implementation of innovative technical or procedural solutions to improve pharmacovigilance and safety operational capabilities
Assist in production and revision of pharmacovigilance and safety procedures, clinical trial documents and forms (e.g., IB, protocols, EDC CRF pages, etc.)
Contribute to regulatory filings and reviews (including BLAs/MAAs/INDs/CTAs), including responses to regulatory queries as needed
Represent pharmacovigilance and safety on project and study teams. Work closely with cross-functional team members to ensure accurate and efficient safety data collection
Work with quality assurance colleagues to address safety-related GCP/GVP compliance issues and support the implementation of corrective actions
Support the development and maintenance of inspection readiness activities, identify and participate in process improvement initiatives
Assist in GCP and GVP inspection readiness and support audits

Qualification

Pharmacovigilance operationsFDA regulationsICH guidelinesGCP complianceSafety databasesICSR processingData reconciliationCommunication skillsNegotiation skillsTeam collaboration

Required

A minimum of 10 years of pharmaceutical experience with a demonstrated focus in PV operations and compliance
Thorough knowledge of relevant FDA and International Conference on Harmonisation (ICH) guidelines, including Good Clinical Practices (GCP) guidelines
Strong knowledge of global safety and pharmacovigilance regulations, guidelines, and industry standards (FDA, EMA, ICH, GVP)
Thorough understanding of Individual Case Safety Reports (ICSR) processing operations, including working with outsourced vendors and Contract Research Organizations
Demonstrated understanding of safety databases, medical literature, and electronic data capture technology
Working knowledge of validated drug safety databases and MedDRA coding dictionary
Skilled at negotiating with business partners or management and influencing senior level leaders regarding matters of significance to the department or more broadly within Kailera
Adept at communicating the pharmacovigilance and safety vision, effectively aligning activities and performance to achieve functional area goals in alignment with corporate goals
Bachelor's degree or equivalent in Public Health, Life Sciences, or other relevant fields is required

Preferred

Experience in other areas of drug development such clinical trial management, regulatory, or quality assurance is a plus
MD, PhD, PharmD, RN or Master's degree is a plus

Benefits

Comprehensive health coverage
Flexible time off
Paid holidays
Year-end shutdown
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants

Company

Kailera Therapeutics

twittertwittertwitter
company-logo
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Funding

Current Stage
Growth Stage
Total Funding
$1B
Key Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M

Leadership Team

leader-logo
Ron Renaud
President & CEO
linkedin
leader-logo
Doug Bakan
Chief Technology Officer
linkedin
Company data provided by crunchbase